// App-Quantinova.ai

NCMP-06 : VENOUS THROMBOEMBOLISM INCIDENCE AND THE IMPACT OF PRE-DISEASED ANTICOAGULATION THERAPY IN GLIOBLASTOMA PATIENTS

Researchers

Presenter

  • Anthony Sloan

Principal Investigators

  • Theresa Elder

  • Ansh Desai

  • Anna Wu

  • Serah Choi

  • Andrew Sloan

Medical Centers

  • Case Western Reserve University School of Medicine, Cleveland, OH

  • University hospitals cleveland medical center, cleveland, OH

  • Department of Pathology and Department of Neurosurgery, Case Western Reserve University and University Hospitals Cleveland Medical Center; Seidman Cancer Center and Case Comprehensive Cancer Center, Cleveland, USA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Deep vein thrombosis

  • Pulmonary embolism

  • Glioblastoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Warfarin

  • Aspirin

  • Albyl-E

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved